Geospatial Data & Transit Mapping · Data Provider / Broker
Biobot Analytics
Wastewater intelligence platform for public health and life sciences.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Biobot Analytics, Inc.
- Entity type
- COMPANY
- Founded
- 2017
- Headquarters
- United States
- Company size
- 10–49
- Market cluster / sector
- Geospatial Data & Transit Mapping
- Market role
- Data Provider / Broker
- Official website
- biobot.io
What Biobot Analytics does
Biobot Analytics operates a B2B software-and-data model. It collects and models wastewater-derived biological signals, packages the resulting intelligence into software platforms and licensed datasets, and sells access to public-sector and enterprise customers. Value is created through proprietary data collection and analytics, with customers using the outputs for surveillance, forecasting, operational planning, research, and clinical trial optimisation.
Category differentiation
Biobot Analytics is not an adtech, martech, or consumer analytics company. It is a B2B health intelligence provider using wastewater data for public health and life sciences decision-making.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Biobot Analytics is a US health data and analytics company focused on wastewater intelligence. Its core offering is a proprietary platform and dataset that converts wastewater sampling into population-level insights on pathogens, substances, and genomic indicators, delivered through dashboards, exports, and APIs. The company serves public health agencies, government bodies, healthcare systems, and pharmaceutical or life sciences organisations that need early detection, forecasting, and geographically granular health monitoring. The business generates revenue through contract-based SaaS access, data licensing, and enterprise or government agreements tied to surveillance coverage, sampling cadence, and access levels. Its value proposition is based on privacy-preserving, aggregated health intelligence derived from wastewater rather than individual patient data, which positions it as an infrastructure layer for public health surveillance, clinical trial planning, and health-related commercial analysis.
Business model & monetisation
Biobot Analytics monetises through recurring SaaS subscriptions, proprietary data licensing, and contract-based government or enterprise agreements. Commercial terms are negotiated rather than openly listed, with pricing likely influenced by geographic coverage, sampling frequency, API or dashboard access, and the scope of data delivered. Public-sector customers buy surveillance access and data feeds, while life sciences customers buy premium analytics, forecasting, and dataset access for research and clinical operations.
- Intelligence platform subscriptions
- Software Subscription
- Government surveillance contracts
- Service Fee
- Dataset licensing
- Pay-per-Use
- API and premium data access
- Pay-per-Use
Products & capabilities
| Product | Description | Source |
|---|---|---|
| Wastewater Intelligence Platform | The Wastewater Intelligence Platform is Biobot Analytics’ core software system that ingests, models, and visualises wastewater-derived biological signals to deliver population-level health intelligence. It provides real-time monitoring, forecasting, and geospatial insights across pathogens, substances, and genomic indicators, enabling early detection of public health risks. The platform is designed for both public sector and life sciences use cases, supporting decision-making with privacy-preserving, aggregated data. |
|
| Biobot Advance | Biobot Advance is a commercial SaaS analytics platform that delivers AI-driven forecasts of disease and substance activity using Biobot’s wastewater dataset. It provides granular ZIP code and county-level time series, predictive risk indicators, and detection signals via dashboards, CSV exports, and APIs. The platform is tailored for pharmaceutical, clinical trial, and commercial teams to optimise research, recruitment, and data-driven decision-making. |
|
| Explore Data | Explore Data is a web-based data access platform that provides public health users with interactive dashboards, maps, and programmatic access to wastewater surveillance metrics. It delivers weekly ZIP code and county-level data across dozens of health indicators, enabling early detection and situational awareness. The platform supports integration with federal systems through APIs and downloadable datasets for analysis and reporting. |
|
| Biobot Data | Biobot Data is a commercial dataset offering that provides structured access to wastewater-derived measurements and trend indicators across the United States. It includes data on pathogens, substance markers, and genomic sequencing outputs, enabling forecasting, analytics, and operational decision-making. The dataset is designed to support public health operations, clinical trials, and commercial strategy through regularly updated, granular insights. |
|
POLARIS7 WORKSPACE
Go deeper on Biobot Analytics and its market context
Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.
- Corporate & subsidiary hierarchy
- Competitor & partner network
- Automated Watchlist briefings
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Biobot Analytics's competitive landscape.
Healthcare data and analytics platform for research and advertising.
Subscription market intelligence and statistics platform for business research.
Enterprise people and company data delivered by API and feeds.
Private markets data and analytics platform for institutional professionals.
Private market intelligence platform for company, funding and prospecting data.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
No sufficiently sourced and dated signals are available for this view.
Explore company relationships
Questions about Biobot Analytics
What is Biobot Analytics?
Biobot Analytics is a US company that turns wastewater sampling data into population-level health intelligence delivered through software platforms, datasets, and APIs.
Who uses Biobot Analytics?
Its paying customers include public health agencies, government bodies, healthcare systems, pharmaceutical companies, clinical trial teams, and research organisations.
How does Biobot Analytics make money?
It earns revenue from SaaS subscriptions, licensed datasets, API access, and contract-based government or enterprise agreements.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Biobot Analytics
Open extended company details, ownership links, and automated signal monitoring in Polaris7.
